Related by context. All words. (Click for frequent words.) 66 nonsurgical treatments 65 hormonal therapies 65 androgen ablation 64 aromatase inhibitor therapy 64 GnRH agonists 62 Radical prostatectomy 62 relapsed ovarian cancer 62 hormonal therapy 61 cranial radiation 61 salpingo oophorectomy 61 lymph node removal 61 androgen deprivation 61 preventive mastectomies 61 preoperative chemotherapy 61 progestin therapy 61 aromatase inhibitors AIs 60 chemotherapy radiotherapy 60 trastuzumab Herceptin ® 60 androgen therapy 60 recurrent ovarian 60 Hormonal therapy 60 Aromatase inhibitors 60 fibrocystic disease 60 oophorectomy 60 prophylactic mastectomy 60 bilateral oophorectomy 59 peritoneal carcinomatosis 59 ovulatory cycles 59 Adjuvant chemotherapy 59 surgical debulking 59 intraperitoneal therapy 59 contralateral breast 59 endometrial carcinoma 59 cystectomy 59 hormone therapy 59 intravenous bisphosphonates 59 GIST tumors 59 hormone therapy estrogen 59 antireflux surgery 59 nonhormonal 59 prophylactic mastectomies 59 ovariectomy 58 orchidectomy 58 cytoreduction 58 intraperitoneal chemotherapy 58 vasomotor symptoms 58 undergoing hysterectomy 58 HAART regimen 58 LHRH agonists 58 endometrial biopsy 58 axillary dissection 58 endometrial cancers 58 abdominal hysterectomy 58 hormone deprivation 58 lymph node dissection 58 pessary 58 anti androgen 58 pyridostigmine 58 tamoxifen therapy 58 orchiectomy 58 adjuvant radiotherapy 57 immunosuppressive medications 57 adjuvant radiation 57 epidural analgesia 57 adrenalectomy 57 seminomas 57 neoadjuvant therapy 57 mTOR inhibitors 57 abnormal Pap smears 57 basal cell cancers 57 recurrent prostate cancer 57 bowel resection 57 ductal breast cancer 57 menopausal symptom 57 invasive biopsy 57 Combination therapy 57 radiation therapy SBRT 57 ovarian hormones 57 liver resection 57 antiandrogen 57 antiangiogenic therapy 57 estrogen therapy 57 intravenous cyclophosphamide 57 antiestrogen therapy 57 oral clodronate 57 breast conserving lumpectomy 56 vaginal hysterectomy 56 urothelial cancer 56 cytotoxic therapy 56 postoperative chemotherapy 56 Calorie restriction 56 masectomy 56 cytoreductive surgery 56 Heavy menstrual bleeding 56 Hormone therapy 56 antiemetics 56 undergo lumpectomy 56 β blockers 56 exemestane 56 cranial irradiation 56 conventional angiography 56 fulvestrant 56 corticosteroid therapy 56 therapeutic regimens 56 LNG IUS 56 secondary amenorrhea 56 androgen hormone 56 operable breast cancer 56 immunosuppressive agents 56 tumor subtype 56 pelvic radiotherapy 56 glandular tissue 56 skin sparing mastectomy 56 pelvic lymphadenectomy 56 androgen hormones 56 EGFR tyrosine kinase inhibitors 56 statin medications 56 GnRH antagonist 56 relieve menopausal symptoms 56 testosterone supplementation 56 symptomatic fibroids 56 nephrectomy 56 breast endometrial 56 chemo therapy 56 external beam radiotherapy 56 ovulation induction 56 Adjuvant therapy 56 somatostatin analogs 56 invasive diagnostic 56 debulking surgery 56 dyslipidemias 56 prostate TURP 56 vaginal estrogen 56 androgen suppression therapy 56 statins cholesterol lowering 56 tamoxifen Nolvadex ® 56 standard chemotherapy regimens 56 radioiodine therapy 56 HER2 positive tumors 56 extrapleural pneumonectomy 56 gynaecologic 56 neoadjuvant chemotherapy 56 Endometrial ablation 56 unsedated colonoscopy 56 cisplatin resistant 56 Surgical excision 56 invasive carcinoma 56 progestins 56 postoperative radiotherapy 56 endometrial hyperplasia 56 antiresorptive 56 bisphosphonate therapy 56 relapsed ALL 56 pre malignant lesions 56 immune suppressants 55 EBRT 55 allogeneic stem cell 55 surgical revascularization 55 mutated K ras 55 aromatase inhibitor 55 antiestrogen 55 prostate cancer metastases 55 treatments 55 biphosphonates 55 sentinel node biopsy 55 urinary leakage 55 polycystic ovarian syndrome PCOS 55 tubal reversal 55 tibolone 55 sentinel lymph node biopsy 55 stimulate ovulation 55 LHRH receptor positive 55 myeloablative 55 undergone hysterectomy 55 AVODART 55 colorectal liver metastases 55 GnRH agonist 55 perimenopausal symptoms 55 H. pylori eradication 55 tumor excision 55 Progestin 55 endogenous estrogen 55 allogeneic HSCT 55 Breast conserving 55 postmenopausal hormones 55 egg retrieval 55 antiarrhythmic medications 55 pre operatively 55 palliation 55 hormonal stimulation 55 recurrent ovarian cancer 55 pharmacological approaches 55 microwave hyperthermia 55 induce ovulation 55 prostate cancer CaP 55 postmenopausal estrogen 55 hepatectomy 55 curative resection 55 immunosuppressant medication 55 peritoneal cancer 55 TACE 55 lymphatic massage 55 topical retinoids 55 chemotherapeutic regimens 55 hormonal deficiencies 55 nonsurgical 55 undergo mastectomy 55 precancerous spots 55 taxane therapy 55 benign prostatic hypertrophy 55 fibroadenomas 55 ovulation inducing 55 Tibolone 55 nonmyeloablative 55 impair fertility 55 Androgen deprivation therapy 55 endoxifen 55 thoracoscopic lobectomy 55 antiplatelet medications 55 undergoing radical prostatectomy 55 pancreaticoduodenectomy 55 IV bisphosphonates 55 tamoxifen 55 menopausal hormone 55 DHEA supplementation 55 intra arterial chemotherapy 55 pamidronate 55 nephron sparing surgery 55 calcineurin inhibitor 55 chemoradiation 55 pulmonary artery banding 55 HIPEC 55 chemopreventive agent 55 chemoradiotherapy 55 thyroid nodules 55 colorectal cancer liver metastases 55 HoLEP 55 oral contraceptive pills 55 mild gestational diabetes 55 retroperitoneal 55 Silicone implants 54 myelosuppressive 54 testosterone injections 54 ovaries surgically 54 pelvic prolapse 54 metastatic bladder 54 adjuvant therapy 54 uterine fibroid tumors 54 androgens 54 liver metastasis 54 chemopreventive agents 54 tumor resection 54 letrozole Femara 54 chemoresistant 54 anti angiogenic agents 54 suppress ovulation 54 ALND 54 recurrent glioblastoma multiforme 54 undergone mastectomies 54 lumbar disk herniation 54 anticlotting drugs 54 atypical hyperplasia 54 alkylating agent 54 clomipramine 54 ovarian stimulation 54 luteal phase 54 uterus womb 54 electro acupuncture 54 LHRH agonist 54 opioid analgesia 54 concurrent chemoradiation 54 cancerous polyp 54 anti coagulant therapy 54 hormonally responsive 54 Cytoxan 54 pharmacological therapies 54 hormone therapy HT 54 Cisplatin 54 taxane chemotherapy 54 VCUG 54 transrectal ultrasound guided 54 levodopa therapy 54 TNF alpha antagonist 54 anti angiogenic drugs 54 gynaecomastia 54 systemic corticosteroid 54 thromboembolic disease 54 VEGF inhibitors 54 hormone blockers 54 amenorrhoea 54 differentiated thyroid 54 renoprotective 54 Smaller incisions 54 facial transplantation 54 repigmentation 54 Colon polyps 54 Clot busting 54 anastrozole 54 uterine fibroid 54 postmenopausal hormone replacement 54 metastatic lesions 54 Topical treatments 54 systemic immunosuppressive 54 cervical lesions 54 antiandrogens 54 pancreatic adenocarcinoma 54 undergone mastectomy 54 adriamycin 54 paclitaxel Taxol R 54 pharmacologic approaches 54 irinotecan chemotherapy 54 prophylactic oophorectomy 54 interpersonal psychotherapy 54 gemcitabine Gemzar 54 cervical ripening 54 seminoma 54 irregular menstrual bleeding 54 prostate cancer HRPC 54 chemotherapy 54 decompensated cirrhosis 54 invasive lobular carcinoma 54 LYSTEDA 54 progesterone hormone 54 lipid lowering drugs 54 uterine fibroid embolization UFE 54 malignant ascites 54 oral anticoagulants 54 BRCA deficient 54 polycystic ovary syndrome PCOS 54 invasive procedures 54 ovarian transplants 54 colon resection 54 preventative mastectomy 54 LHRH analogues 54 antiarrhythmic drugs 54 skeletal metastases 54 premenopausal 54 Oral contraceptives 54 loop diuretics 54 radiotherapy chemotherapy 54 hormone receptor negative 54 advanced HER2 positive 54 adjuvant therapies 54 urothelial carcinoma 54 iron chelation 54 MRgFUS 54 preventive mastectomy 54 trastuzumab Herceptin 54 immunosuppressive regimen 54 paricalcitol 54 radical hysterectomy 54 Postmenopausal 54 hyaluronic acid fillers 54 gastroesophageal junction 54 flutamide 54 blood clot dissolving 54 hepatic metastases 54 goserelin 54 antihypertensive therapy 54 immunosuppressant medications 54 estrogen hormone therapy 54 lymphadenectomy 54 Kegel exercises 54 HER2 positive cancers 54 intensive lipid lowering 54 leiomyomas 54 Surgical resection 54 thromboembolisms 54 alpha blocker 54 medically inoperable 54 protamine 54 Radiofrequency ablation 54 symptomatic paroxysmal AF 54 prostate cancer CRPC 53 adjuvant hormonal therapy 53 transplantation HCT 53 radiation chemoradiation 53 unsightly veins 53 benign nodules 53 surgical excision 53 conjugated equine estrogen 53 Thal Dex 53 estrogen progesterone 53 antiplatelet therapies 53 KRAS status 53 neoadjuvant chemoradiotherapy 53 lung tumors 53 antiangiogenic agents 53 radiochemotherapy 53 MMP inhibitors 53 Ovary removal 53 antianginal 53 breast carcinoma 53 folinic acid 53 hepatic resection 53 steroid prednisone 53 neoadjuvant radiation 53 N acetylcysteine 53 PAP smears 53 neoplastic cells 53 esophagogastric 53 trabeculectomy 53 mycophenolate mofetil 53 pentoxifylline 53 perioperative complications 53 antihormonal 53 Oral corticosteroids 53 nodal dissection 53 flavopiridol 53 female hormones estrogen 53 radical prostatectomy RP 53 hormone refractory 53 endostatin 53 Sentinel node biopsy 53 lung cancer NSCLC 53 androgen excess 53 Malignant tumors 53 nonoperative treatment 53 melanoma tumors 53 FSAD 53 radical nephrectomy 53 cediranib 53 overactive bladder symptoms 53 hypogonadal men 53 NMDA antagonists 53 ovarian suppression 53 sonographic appearance 53 clot dissolving drugs 53 chemo radiotherapy 53 prenatal multivitamin 53 epidural anesthesia 53 adenomyosis 53 undergo radical prostatectomy 53 thymectomy 53 antirejection 53 L dopa 53 abnormal Pap tests 53 pharmacologic intervention 53 malignant growths 53 Tamoxifen 53 nonmelanoma skin cancers 53 progesterone receptor negative 53 intestinal polyps 53 TURP 53 esophagectomy 53 pre menopausal 53 inhaled bronchodilators 53 bilateral orchiectomy 53 analgesic medications 53 premature menopause 53 estrogen 53 CMV infections 53 recombinant follicle stimulating 53 metastatic RCC 53 immune suppressing 53 osteosarcomas 53 renal tumors 53 treating menopausal symptoms 53 coronary arteriography 53 sacrocolpopexy 53 immunosuppressive therapies 53 enlarged prostate glands 53 antidepressant therapy 53 postmenopausal hormone therapy 53 treat enlarged prostate 53 abnormal Pap test 53 dietary modification 53 uncomplicated pregnancies 53 endocrine therapies 53 axillary node dissection 53 spontaneous regression 53 lung metastasis 53 caspofungin 53 herceptin 53 precancerous tissue 53 myomectomy 53 myoma 53 premenstrual syndrome PMS 53 thiazide diuretic 53 rtPA 53 ALA PDT 53 SHBG levels 53 Anti inflammatories 53 adjuvant chemotherapy 53 prophylactic preventive 53 immunosuppressant drugs 53 precancerous condition 53 limb sparing 53 patients undergoing chemotherapy 53 radical mastectomy 53 noninvasive outpatient 53 Androgens 53 neoadjuvant setting 53 ZOLINZA 53 genital tract infections 53 mastectomy chemotherapy 53 tamoxifen raloxifene 53 endometrial ablation 53 hormonally sensitive 53 EGFR inhibitors 53 percutaneous cryoablation 53 gastrointestinal stromal tumors GIST 53 olaparib 53 hypofractionated radiation 53 menopausal hormone therapy 53 urinary symptoms 53 partial nephrectomy 53 Smac mimetics 53 bronchogenic carcinoma 53 endocrine therapy 53 preoperative radiotherapy 53 IDH mutations 53 node dissection 53 aromatase inhibitors 53 dexamethasone Decadron 53 clinically localized prostate 53 dexrazoxane 53 HbF 53 precancer 53 lipid lowering agents 53 pharmacological treatments 53 tumescent liposuction 53 Faslodex 53 anthracycline taxane 53 beta blocker therapy 53 heavy menstrual bleeding 53 OPCAB 53 hypertrophic scars 53 radical mastectomies 53 ultrasonic liposuction 53 psychotherapeutic interventions 53 erlotinib Tarceva 53 transarterial chemoembolization 53 Hormone pills 53 Mitomycin C 53 neoadjuvant 53 HER2 positive breast 53 Herceptin trastuzumab 53 superficial bladder cancer 53 AGILECT R 53 imatinib Gleevec 53 anticoagulant medications 53 menstrual bleeding 53 immune suppressant 53 irregular menstrual cycles 53 AMOR IPAT 53 lipid lowering therapy 53 TRUS biopsy 53 chemotherapy docetaxel 53 antibiotic regimens 53 lenalidomide dexamethasone 53 clot busters 53 chronic prostatitis 52 induce remission 52 urethral stricture 52 cisplatin chemotherapy 52 reoperations 52 partial hysterectomy 52 postoperative AF 52 multimodality therapy 52 surgical decompression 52 bilateral mastectomy 52 densest breasts 52 Shark cartilage 52 inhaled glucocorticoids 52 perioperative morbidity 52 APTIVUS r 52 antiplatelet medication 52 colonoscopic 52 Oestrogen 52 perforated colons 52 transarterial 52 gastrectomy 52 Zevalin consolidation 52 dysfunctional voiding 52 adrenal hormone 52 uterine cancers 52 zoledronate 52 lipomas 52 progestogen 52 ovulatory dysfunction 52 Src inhibitors 52 oral anticoagulation 52 uric acid lowering 52 ER CHOP 52 severe menopausal symptoms 52 Paraplatin ® carboplatin 52 catheter angiography 52 nonalcoholic steatohepatitis NASH 52 iniparib 52 nifedipine 52 anticancer therapy 52 postsurgery 52 anticholinergic drugs 52 spinal metastases 52 serum testosterone levels 52 acid suppressing 52 progestogens 52 hMG 52 mammary cancers 52 HER2 overexpression 52 surgically induced 52 trans retinoic acid ATRA 52 invasive coronary angiography 52 glycoprotein IIb IIIa inhibitors 52 immunosuppressive medication 52 heparins 52 luteal 52 pCR 52 ovarian cervical 52 decompressive surgery 52 lymph node biopsies 52 anticoagulants blood thinners 52 androgen deficiency 52 bilateral mastectomies 52 lichen planus 52 DHEA supplements 52 nodal metastasis 52 polyp detection 52 sex hormones estrogen 52 prednisone prednisolone 52 lobular cancer 52 vasodilators 52 estrogen receptor negative 52 percutaneous drainage 52 hormone androgen 52 cystoscopic 52 pelvic malignancies 52 transurethral resection 52 sonographically guided 52 laparoscopic technique 52 reimplantation 52 relapsed MM 52 melanoma lesions 52 androgen 52 undergone hysterectomies 52 advanced metastatic prostate 52 metastatic melanomas 52 RYGB surgery 52 serous ovarian cancer 52 hormonal contraception 52 VA# [002] 52 pancreatic lung 52 cilengitide 52 allogeneic SCT 52 pharmacological interventions 52 factor TNF 52 sentinel nodes 52 tumor histology 52 maximally tolerated lipid lowering 52 adenoid tissue 52 DMARDS 52 colectomy 52 bisphosphonate drugs 52 rHuEPO 52 recurrent UTIs 52 noscapine 52 chemotherapies 52 hormonal 52 truncal 52 radical cystectomy 52 prostate cancer PCa 52 potentially hepatotoxic 52 osteoarthritic 52 female hormone progesterone 52 pancreatic cyst 52 autologous transplants 52 parathyroid 52 folate supplementation 52 Flu Cy 52 topical testosterone 52 surgical biopsies 52 hip resurfacing arthroplasty 52 strontium ranelate 52 COREG 52 chemotherapy regimen 52 basal cell nevus syndrome 52 ovary removal 52 electrical cardioversion 52 irregular menses 52 fibrinolytic 52 antirheumatic 52 biliary tract cancer 52 chemotheraphy 52 thyroxine 52 cervical lymph nodes 52 vascular abnormalities 52 Menopausal hormone therapy 52 atypical ductal hyperplasia 52 neostigmine 52 singleton pregnancy 52 Minimally invasive procedures 52 gynecologic procedures 52 chemo resistant 52 standby tamoxifen 52 hypogonadal 52 Bone marrow transplantation 52 menstrual migraine 52 TNF alpha inhibitor 52 lactational 52 vulvar pain 52 anastrazole 52 hyperandrogenism 52 hydroxychloroquine 52 androgen suppression 52 body contouring procedure 52 nonsurgical treatment 52 peri menopausal 52 autologous transplantation 52 laproscopic procedure 52 egg follicles 52 colon tumors 52 bladder bowel 52 iron chelation therapy 52 NATRECOR ® 52 treat menopausal symptoms 52 antiretroviral regimens 52 Cristofanilli 52 Doxil ® 52 artificial sphincter 52 removed laparoscopically 52 partial mastectomy 52 thromboprophylaxis 52 synthetic progestin 52 Schaffir 52 perimenopausal women 52 urethral strictures 52 antioxidant supplementation 52 topical NSAIDs 52 citalopram Celexa 52 epithelial ovarian cancer 52 female genital tract 52 micrometastases 52 therapies 52 prednisone steroid 52 infantile hemangiomas 52 erlotinib Tarceva ® 52 cytoreductive nephrectomy 52 curative therapies 52 postoperative morbidity 52 interferon IFN 52 pharmacologic stress 52 ovarian function 52 Riluzole 52 sympathectomy 52 pregabalin 52 estrogen estradiol 52 oncologic outcomes 52 immuno suppressants 52 lapatinib Tykerb 52 postmenopausal hormone 52 axillary lymph node dissection 52 adjuvant tamoxifen 52 transdermal gel 52 antifungal therapy 52 mucinous 52 nonpharmacologic 52 HER2 negative 52 mastopexy 52 curable cancers 52 empiric therapy 52 cardiotoxic 52 PSADT 52 ductal lavage 52 abiraterone 51 therapy BHRT 51 Nonsurgical 51 Fat grafting 51 spontaneously regress 51 nalbuphine 51 immunosuppressants 51 abdominal ultrasounds 51 premenopausal women 51 mistletoe extract 51 rituximab Rituxan 51 hormonal contraceptive 51 paclitaxel cisplatin 51 imexon 51 pelvic irradiation 51 abnormal pap smears 51 overexpress HER2 51 armpit lymph nodes 51 fibrocystic 51 immunosuppressive regimens 51 alkylating agents 51 epirubicin 51 precocious puberty 51 non ulcer dyspepsia 51 prostate carcinoma 51 micronized progesterone 51 androgen ablation therapy 51 amenorrhea 51 PARP inhibitors 51 HER2 positive metastatic breast 51 prostate pancreatic 51 excisional 51 oral anticoagulant therapy 51 proliferative disorders 51 bone grafting procedures 51 painful menstrual periods 51 TNF inhibitor 51 fibroids endometriosis 51 mycophenolate mofetil MMF 51 Sexual dysfunction 51 isoflavone supplements 51 hyperplasia BPH 51 vaginal atrophy 51 dobutamine 51 metastatic malignant melanoma 51 Prostate tumors 51 SERMs 51 epithelial ovarian 51 antiplatelet drugs 51 intravesical therapy 51 methotrexate therapy 51 allogeneic transplant 51 PASI scores 51 antihyperglycemic 51 anal lesions 51 contraceptive Pill 51 dose paroxetine mesylate 51 enlarged prostates 51 FIRMAGON 51 5FU 51 flecainide 51 oral NSAIDs 51 Natalizumab 51 non sedating antihistamines 51 Anthracycline 51 postoperative mortality 51 radiotherapy RT 51 multivitamin supplements 51 retinoids 51 metastatic lung cancer 51 untreated celiac disease 51 keloid scars 51 saline infusion 51 muscle dysmorphia 51 mastectomies 51 recombinant FSH 51 cytotoxic therapies 51 Coronary artery bypass 51 targeted biologic therapies 51 recurrent metastatic 51 adrenal function 51 menopausal symptoms 51 incidentalomas 51 ovarian carcinoma 51 nonpharmacological 51 resectable 51 chemotherapy regimens 51 antimicrobial prophylaxis 51 Fludarabine 51 pelvic girdle pain 51 meniscectomy 51 intravenous chemotherapy 51 serum calcium levels 51 palliative radiotherapy 51 osteoporotic compression fractures 51 Hysterectomies 51 carbohydrate polymers 51 chemotherapy cisplatin 51 fundoplication 51 selenium supplementation 51 Chemical peels 51 medroxyprogesterone 51 paclitaxel Taxol 51 sexual arousal disorder 51 squamous cell lung cancer 51 antiangiogenic 51 fibrate drugs 51 invasive lobular 51 cardiac glycosides 51 testicular tumors 51 myomas 51 Anastrozole 51 mycosis fungoides 51 ASC J9 51 therapeutic armamentarium 51 corifollitropin alfa 51 iron chelators 51 menstrual suppression 51 needle aspiration 51 liver metastases 51 tonsil removal 51 benign uterine 51 Zolinza 51 bevacizumab Avastin 51 radiofrequency ablation RFA 51 molar pregnancy 51 tolterodine 51 antioxidant vitamin supplements 51 keloid 51 prostatectomy 51 unruptured aneurysm 51 raloxifene Evista 51 molecular abnormalities 51 metastatic gastric 51 antibiotic prophylaxis 51 mutated KRAS gene 51 male hormone androgen 51 infliximab Remicade 51 verapamil 51 Bone marrow transplant 51 insulin sensitization 51 GnRH analogues 51 chlamydial 51 recurrent bladder 51 tumor subtypes 51 B7 H3 51 Liver transplants 51 Platinol ® cisplatin 51 osteoid 51 Adiana procedure 51 oral rivaroxaban 51 HER2 positive breast cancer 51 narcolepsy cataplexy 51 caesarean delivery 51 mitomycin C 51 nonoperative 51 phosphate binders 51 conformal radiotherapy 51 antithrombotic therapy 51 ACAT2 51 Femara letrozole 51 uterus fallopian tubes 51 Calcium vitamin D 51 pituitary hormone 51 Balloon sinuplasty 51 radiosensitivity 51 BoNTA 51 visilizumab 51 invasive biopsies 51 estrogen progestin combination 51 ovarian hyperstimulation 51 Testosterone gel 51 adjuvant cisplatin 51 biochemical relapse 51 surgical debridement 51 bioidentical estrogen 51 laparoscopic colon 51 endoscopic resection 51 antiplatelet therapy 51 CFTR inhibitors 51 GISTs 51 SLNB 51 RALP 51 breast cancer subtypes 51 transdermal estrogen 51 anthracycline chemotherapy 51 atrophic gastritis 51 idarubicin 51 overlapping toxicities 51 mammographic breast density 51 papillomas 51 Intrauterine devices 51 CYP#D# inhibitor 51 ablative lasers 51 dystrophic 51 chemoprevention 51 estrogen receptor beta 51 suppressive therapy 51 unresectable stage 51 dyspareunia 51 corticosteroid injection 51 hormones progesterone 51 Dr. Julie Buring 51 breast tenderness 51 acetylcholinesterase inhibitors 51 denser breasts 51 lobular carcinoma 51 metastatic adenocarcinoma 51 calcineurin inhibitors 51 curative therapy 51 neutropenic patients 51 LUTS 51 clodronate 51 nephrectomies 51 genital lesions 51 opiod 51 anticoagulation therapy 51 postsurgical 51 microtubule inhibitor 51 bacterial vaginosis 51 mu opioid 51 DAPT 51 vitamin D analogs 51 thyroglobulin 51 insulin sensitizing 51 Estrogens 51 metastatic uveal melanoma 51 eflornithine 51 pre cancerous polyps 51 acupoint stimulation 51 H2 antagonists 51 guideline concordant 51 osteopenic 51 menstruate 51 homoeopathic remedies